Calcitriol
Calcitriol.JPG

Calcitriol

CLINICAL USE

Vitamin D analogue:
  • Promotes intestinal calcium absorption
  • Suppresses PTH production and release

    DOSE IN NORMAL RENAL FUNCTION

  • Orally: 250 nanograms daily or on alternate days, increased if necessary in steps of 250 nanograms at intervals of 2–4 weeks. Usual dose 0.5–1 micrograms daily
  • IV: treatment of hyperparathyroidism in haemodialysis patients: initially 500 nanograms (10 nanograms/kg) 3 times a week, increased if necessary in steps of 250–500 nanograms at intervals of 2–4 weeks. Usual dose 0.5–3 micrograms 3 times a week after dialysis

    PHARMACOKINETICS

  • Molecular weight                           :416.6
  • %Protein binding                           :99.9
  • %Excreted unchanged in urine     : 7–10
  • Volume of distribution (L/kg)       :No data
  • half-life – normal/ESRD (hrs)      :9–10/18–20

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function. Titrate to response
  • 10 to 20     : Dose as in normal renal function. Titrate to response
  • <10           : Dose as in normal renal function. Titrate to response

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Unlikely to be dialysed. Dose as in normal renal function
  • HD                     :Not dialysed. Dose as in normal renal function
  • HDF/high flux   :Not dialysed. Dose as in normal renal function
  • CAV/VVHD      :Unknown dialysability. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • The effects of vitamin D may be reduced in patients taking barbiturates or anticonvulsants
  • Increased risk of hypercalcaemia if thiazides given with vitamin D

    ADMINISTRATION

    Reconstition

    Route

    Oral, IV

    Rate of Administration

    Bolus

    Comments

    OTHER INFORMATION

  • Check plasma calcium concentrations at regular intervals (initially weekly)
  • Dose of phosphate-binding agent may need to be modified as phosphate transport in the gut and bone may be affected
  • Hypercalcaemia and hypercalciuria are the major side effects, and indicate excessive dosage



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs